Sign in

CIK 0001175680

  • Non-accelerated filer
  • Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
Operating
EIN
753056237
Phone
+1 360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. 4 Grant or award Chief Technology Officer acquired 12,428 shares (grant or award)
  2. 4 Grant or award CFO acquired 9,824 shares (grant or award)
  3. 4 Grant or award CMO acquired 13,849 shares (grant or award)
  4. 4 Grant or award CMO acquired 18,793 shares (grant or award)
  5. 4 Grant or award Chief Technology Officer acquired 13,020 shares (grant or award)
  6. 4 Grant or award CFO acquired 10,292 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award President acquired 646,552 shares (grant or award)
  9. 4 Grant or award CMO acquired 9,457 shares (grant or award)
  10. 4 Grant or award Chief Technology Officer acquired 8,965 shares (grant or award)
  11. 4 Grant or award CFO acquired 7,086 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award CFO acquired 8,313 shares (grant or award)
  18. 4 Grant or award CMO acquired 11,094 shares (grant or award)
  19. 4 Grant or award Chief Technology Officer acquired 10,516 shares (grant or award)
  20. 4 Grant or award Chief Technology Officer acquired 6,588 shares (grant or award)

Page 3 of 22 · 435 filings